A new additional drug in the fight against the opioid overdose crisis has slowly been making its way across the country and ...
The start of a so-called rolling review formally begins an FDA evaluation of a closely watched drug that’s important to the biotech’s future, but faces questions about its sales potential.
The start of the opioid epidemic is ironically linked to a drug that was supposed to help people suffering from moderate to ...
Some argue a need for more potent — and pricier — overdose reversal drugs; others frame that effort as drugmakers peddling ...
The primary use of proceeds will be for completing the remaining clinical development of AVERSA Fentanyl and submission of ...
This issue of the Mass Torts Update addresses the United Judicial Panel on Multidistrict Litigation ordering the ...
The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development ...
FDA Approves Methylphenidate Patch for Teens With ... chronic pain in patients requiring a continuous, around-the-clock opioid analgesic. News, July 08, 2010 FDA Clears Liquid-Cooled Fiber for ...
The House Committee on Veterans' Affairs approved a pair of cannabis and psychedelics bills on Tuesday . Committee members ...
Analyst Tim Chiang of Capital One Financial maintained a Buy rating on Amphastar Pharmaceuticals (AMPH – Research Report), retaining the ...
~ Webcast Replay Available on Ensysce's Investor Relations Website ~ ...